Vaccination in MS

Choosing a flexible treatment approach that adapts to other healthcare needs, such as vaccination protocols, is becoming increasingly important in the management of MS.1 By altering immune cell counts, the use of some DMTs can affect vaccination effectiveness and patient’s immunisation readiness and should therefore be carefully considered when making treatment decisions.2

 

Watch the videos below to find out more about vaccination!

Immunodepressed Patients

Vaccination of Immunosuppressed Patients

CONTINUE WATCHING

Type of Vaccines

Vaccination and MS: Risk and Effect

Pneumococcal Disease

CONTINUE WATCHING

Influenza Virus

Varicella Zoster Virus

CONTINUE WATCHING

Travel Vaccination of Immunosuppressed Travellers

Biogen-104400.
Date of preparation: April 2021.

References:
1. Pardo G, Jones DE. The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations. J Neurol. 2017;264(12):2351-2374.
2. Giovannoni G, Smets I, Reyes S. MS Minute: The COVID-19 Vaccine & Vaccine Readiness in MS. Pract Neurol. 2021:77-81.